Stifel cuts Caesars Entertainment stock target to $51
Stifel analysts adjusted their outlook on Caesars Entertainment (NASDAQ:CZR), lowering the price target to $51.00 from the previous $54.00 while still maintaining a Buy rating on the stock. Currently ...
Quanta Services price target raised to $388 from $374 at Stifel
Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...
Take-Two price target raised to $223 from $220 at Stifel
Stifel analyst Drew Crum raised the firm’s price target on Take-Two (TTWO) to $223 from $220 and keeps a Buy rating on the shares. The firm ...
Stifel maintains Buy on Revolve stock with $41 target
Stifel analysts kept a Buy rating on Revolve Group (NYSE:RVLV) shares, maintaining a $41.00 price target. The firm is ...
Fastenal price target lowered to $82 from $86 at Stifel
Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...
Canada’s Eight Capital to Shut Down as Stifel Swoops In for Bankers
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
manilatimes15h
Stifel Financial Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call
Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...
24/7 Wall St1d
2025 Bull Market: Here's How High These Wall Street Analysts Think the Market Could Go In 2025
Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...
Legal Sports Report5d
Stifel Initiates FanDuel Parent Flutter With Buy Rating
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
Kits Eyecare FY2024 EPS Estimate Increased by Stifel Canada
Equities researchers at Stifel Canada lifted their FY2024 earnings per share (EPS) estimates for shares of Kits Eyecare in a research note issued on Monday, January 20th. Stifel Canada analyst M.
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...